Use App
Trending
News
Earnings
Newsletters
Advertise
All
DIA
0.03%
SPY
0.29%
QQQ
0.45%
Trending
HOLO
36.21%
KVUE
1.72%
ZBCN.X
12.39%
BETR
84.11%
CAW.X
5.76%
DIS
1.25%
CLSK
11.07%
BA
0.14%
SMLR
13.92%
AGRI
131.13%
HOLO
36.21%
KVUE
1.72%
ZBCN.X
12.39%
BETR
84.11%
CAW.X
5.76%
DIS
1.25%
CLSK
11.07%
BA
0.14%
SMLR
13.92%
AGRI
131.13%
home
Symbol
DHR
DHR
Danaher Corp.
4,702
Loading...
Loading...
Feed
News
Sentiment
Earnings
Fundamentals
Info
News
all
press releases
Can Danaher's Diagnostics Unit Sustain Growth Amid Lower Sales in China?
DHR's Diagnostics unit posts steady Q2 growth, led by Beckman Coulter demand, while China headwinds weigh on results.
Zacks
·
9h ago
Share to Feed
More News
Danaher's Life Sciences Segment Shrinks: What's the Path Forward?
DHR's Life Sciences unit faces revenue declines from weak demand, but new products and biotech advances offer growth potential.
Zacks
·
6d ago
Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?
HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound.
Zacks
·
7d ago
Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?
DHR's Biotechnology unit grows 6% in Q2, driven by bioprocessing, despite weakness in research equipment demand.
Zacks
·
11d ago
Danaher Gains From Business Strength Amid Persisting Headwinds
DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.
Zacks
·
20d ago
Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
·
25d ago
Danaher (DHR) Up 6.8% Since Last Earnings Report: Can It Continue?
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
·
1mo ago
Danaher (DHR) Just Overtook the 200-Day Moving Average
When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?
Zacks
·
1mo ago
CVS or DHR: Which Is the Better Value Stock Right Now?
CVS vs. DHR: Which Stock Is the Better Value Option?
Zacks
·
1mo ago
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.
Zacks
·
2mo ago
Latest DHR News
View
Advertisement.
Remove ads.
Advertisement.
Remove ads.
Advertisement.
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile